NASDAQ:DCPH Deciphera Pharmaceuticals (DCPH) Insider Trading & Ownership $14.02 +0.04 (+0.29%) (As of 06/9/2023 ET) Add Compare Share Share Today's Range$13.67▼$14.1050-Day Range$13.28▼$15.9652-Week Range$10.14▼$22.76Volume627,585 shsAverage Volume728,112 shsMarket Capitalization$1.10 billionP/E RatioN/ADividend YieldN/APrice Target$21.78 Insider TradesProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainabilityProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability Deciphera Pharmaceuticals (NASDAQ:DCPH) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage4.43%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)$30.15 MNumber OfInsiders Selling(Last 12 Months)6Amount OfInsider Selling(Last 12 Months)$302,078.73 DCPH Insider Buying and Selling by Quarter Get DCPH Insider Trade Alerts Want to know when executives and insiders are buying or selling Deciphera Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Deciphera Pharmaceuticals Insider Trades History Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails5/10/2023Dennis Leo WalshDirectorBuy11,000$13.86$152,460.0011,000 3/21/2023Steven L. HoerterCEOSell7,500$15.57$116,775.00 2/16/2023Daniel C MartinInsiderSell1,159$15.10$17,500.9058,381 2/16/2023Matthew L ShermanEVPSell971$15.10$14,662.1088,145 2/16/2023Thomas Patrick KellyCFOSell1,370$15.10$20,687.0058,795 1/24/2023Brightstar Associates LlcMajor ShareholderBuy1,666,666$18.00$29,999,988.0019,718,014 1/17/2023Daniel Lee FlynnInsiderSell2,403$21.24$51,039.7243,695 10/3/2022Matthew L ShermanEVPSell2,587$18.73$48,454.5174,297 6/16/2022Jama PitmanInsiderSell1,298$10.75$13,953.5036,661 6/16/2022Matthew L ShermanEVPSell1,768$10.75$19,006.0076,884 (Data available from 1/1/2013 forward) DCPH Insider Trading Activity - Frequently Asked Questions Who is on Deciphera Pharmaceuticals's Insider Roster? The list of insiders at Deciphera Pharmaceuticals includes Brightstar Associates Llc, Daniel C Martin, Daniel Lee Flynn, Dennis Leo Walsh, Jama Pitman, James Arthur Bristol, Matthew L Sherman, Michael Douglas Taylor, Steven L. Hoerter, and Thomas Patrick Kelly. Learn more on insiders at DCPH. What percentage of Deciphera Pharmaceuticals stock is owned by insiders? 4.43% of Deciphera Pharmaceuticals stock is owned by insiders. Learn more on DCPH's insider holdings. Which Deciphera Pharmaceuticals insiders have been buying company stock? The following insiders have purchased DCPH shares in the last 24 months: Brightstar Associates Llc ($44,789,768.00), and Dennis Leo Walsh ($152,460.00). How much insider buying is happening at Deciphera Pharmaceuticals? Insiders have purchased a total of 3,156,644 DCPH shares in the last 24 months for a total of $44,942,228.00 bought. Which Deciphera Pharmaceuticals insiders have been selling company stock? The following insiders have sold DCPH shares in the last 24 months: Daniel C Martin ($17,500.90), Daniel Lee Flynn ($63,402.02), Jama Pitman ($13,953.50), Matthew L Sherman ($179,226.84), Steven L. Hoerter ($116,775.00), and Thomas Patrick Kelly ($33,067.40). How much insider selling is happening at Deciphera Pharmaceuticals? Insiders have sold a total of 25,433 Deciphera Pharmaceuticals shares in the last 24 months for a total of $423,925.66 sold. More Insider Trading Tools from MarketBeat Related Companies: OPK Insider Trading SMMT Insider Trading AVDL Insider Trading BHVN Insider Trading MIRM Insider Trading MRUS Insider Trading PNT Insider Trading ARVN Insider Trading MNKD Insider Trading KNSA Insider Trading Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: Time To Buy Regional Banks? Insider Buying Says Yes2 Cheap Stocks And 1 Cheap Sector The Insiders Are BuyingTyson Insiders Buy Shares At Multi-Year Low3 High-Yield Banks Insiders Are Buying Insiders Drive Volatility For Keurig Dr Pepper This page (NASDAQ:DCPH) was last updated on 6/10/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Deciphera Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.